Reviva Pharmaceuticals Ownership | Who Owns Reviva Pharmaceuticals?

Reviva Pharmaceuticals Ownership Summary

Reviva Pharmaceuticals is owned by 43.08% institutional investors, 7.27% insiders, and 49.65% retail investors. Armistice capital is the largest institutional shareholder, holding 8.12% of RVPH shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.75% of its assets in Reviva Pharmaceuticals shares.

RVPH Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Reviva Pharmaceuticals	43.08%	7.27%	49.65%
Sector	Healthcare Stocks	488.30%	11.08%	-399.38%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Armistice capital	2.69M	8.12%	$1.03M
Heights capital management	1.83M	5.52%	$697.38K
Millennium management	1.80M	5.34%	$3.27M
Vanguard group	1.38M	4.10%	$2.51M
Schonfeld strategic advisors	1.06M	3.13%	$1.92M
683 capital management	1.00M	3.02%	$381.10K
Geode capital management	311.70K	0.92%	$564.28K
Susquehanna group, llp	202.01K	0.60%	$365.64K
Sabby management	169.92K	0.51%	$64.76K
Blackrock	102.93K	0.43%	$131.75K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Heights capital management	1.83M	0.19%	$697.38K
Sabby management	169.92K	0.12%	$64.76K
Emc capital management	128.41K	0.03%	$49.00K
683 capital management	1.00M	0.03%	$381.10K
Armistice capital	2.69M	0.02%	$1.03M
Schonfeld strategic advisors	1.06M	0.01%	$1.92M
Avidity partners management lp	138.00K	0.01%	$52.59K
Pale fire capital se	25.00K	0.00%	$32.00K
Nri wealth management lc	12.38K	0.00%	$4.72K
Drive wealth management	20.00K	0.00%	$7.62K

Top Buyers

Holder	Shares	% Assets	Change
Armistice capital	2.69M	0.02%	2.69M
Heights capital management	1.83M	0.19%	1.83M
683 capital management	1.00M	0.03%	1.00M
Vanguard group	1.38M	-	359.34K
Sabby management	169.92K	0.12%	169.92K

Top Sellers

Holder	Shares	% Assets	Change
Woodline partners lp	-	-	-684.80K
Parkman healthcare partners	-	-	-514.27K
Tang capital management	-	-	-510.33K
Schonfeld strategic advisors	1.06M	0.01%	-457.80K
Marshall wace, llp	-	-	-216.50K

New Positions

Holder	Shares	% Assets	Change	Value
Heights capital management	1.83M	0.19%	1.83M	$697.38K
683 capital management	1.00M	0.03%	1.00M	$381.10K
Sabby management	169.92K	0.12%	169.92K	$64.76K
Wolverine trading	14.26K	-	14.26K	$25.81K
Sg americas securities	11.56K	-	11.56K	$4.00K

Sold Out

Holder	Change
Qube research	-50.00
Wolverine asset management	-122.00
Wells fargo & company/mn	-175.00
Jpmorgan chase	-235.00
Advisor group	-250.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	51	-3.77%	14,278,367	98.90%	43	9.18%	22	-21.43%	9	-
Mar 31, 2025	53	8.16%	7,348,669	-4.96%	22	4.24%	29	-3.33%	9	12.50%
Dec 31, 2024	49	32.43%	7,732,309	-22.27%	22	2.64%	30	100.00%	8	-11.11%
Sep 30, 2024	37	5.71%	9,947,227	45.22%	41	5.10%	15	-25.00%	9	80.00%
Jun 30, 2024	35	6.06%	6,849,687	22.89%	28	5.30%	20	25.00%	5	-16.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.19M	1.75%	-26.06K
Vanguard US Total Market Shares ETF	700.44K	1.50%	-
Vanguard Institutional Extnd Mkt Idx Tr	393.89K	0.58%	-179.49K
Fidelity Extended Market Index	224.04K	0.33%	-1.84K
BlackRock Extended Equity Market K	48.10K	0.15%	-20.00
Northern Trust Extended Eq Market Idx	48.87K	0.10%	-
NT Ext Equity Mkt Idx Fd - L	48.87K	0.10%	-
Fidelity Total Market Index	68.55K	0.10%	-
iShares Micro-Cap ETF	47.06K	0.10%	-
Extended Equity Market Fund K	46.66K	0.10%	-931.00

Recent Insider Transactions

Date	Name	Role	Activity	Value
Nov 18, 2022	Patel Purav	-	Buy	$14.07K
Sep 30, 2022	Narayan Prabhu	Chief Financial Officer	Buy	$83.00K
Sep 08, 2022	VEDANTA PARTNERS, LLC	-	Buy	$86.96
Sep 08, 2022	VEDANTA PARTNERS, LLC	-	Buy	$51.38
Sep 08, 2022	VEDANTA PARTNERS, LLC	-	Buy	$2.09M

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	-	-
2023 Q4	-	-
2023 Q2	-	-
2022 Q4	1	-

RVPH Ownership FAQ

Who Owns Reviva Pharmaceuticals?

Reviva Pharmaceuticals shareholders are primarily institutional investors at 43.08%, followed by 7.27% insiders and 49.65% retail investors. The average institutional ownership in Reviva Pharmaceuticals's industry, Biotech Stocks , is 307.10%, which Reviva Pharmaceuticals falls below.

Who owns the most shares of Reviva Pharmaceuticals?

Reviva Pharmaceuticals’s largest shareholders are Armistice capital (2.69M shares, 8.12%), Heights capital management (1.83M shares, 5.52%), and Millennium management (1.8M shares, 5.34%). Together, they hold 18.98% of Reviva Pharmaceuticals’s total shares outstanding.

Does Blackrock own Reviva Pharmaceuticals?

Yes, BlackRock owns 0.43% of Reviva Pharmaceuticals, totaling 102.93K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 131.75K$. In the last quarter, BlackRock increased its holdings by 11.07K shares, a 12.05% change.

Who is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Heights capital management is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.19% of its assets in 1.83M Reviva Pharmaceuticals shares, valued at 697.38K$.

Who is the top mutual fund holder of Reviva Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Reviva Pharmaceuticals shares, with 1.75% of its total shares outstanding invested in 1.19M Reviva Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools